Clinical and molecular studies of a thyrotropin-secreting pituitary adenoma

Mary Samuels, W. M. Wood, D. F. Gordon, B. K. Kleinschmidt-DeMasters, K. Lillehei, E. C. Ridgway

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

A 40-year-old woman, who had previously received radioactive iodine for hyperthyroidism, presumably due to Graves' disease, subsequently was found to have inappropriately elevated serum TSH and α-subunit levels and a pituitary adenoma. Detailed clinical studies revealed marked serum TSH elevations (~100 mU/L) with no circadian variation, but with 7 pulses/24 h. Serum α-subunit levels averaged 2.5 μg/L, with 13 pulses/24 h. Neither serum TSH nor α-subunit responded to TRH stimulation, nor did serum TSH change during dopamine infusion, but α-subunit levels did decline slightly. In contrast, during somatostatin infusion, serum TSH declined to 30% of baseline levels, while α-subunit levels did not change. Pituitary adenoma tissue obtained at the time of transsphenoidal surgery immunostained weakly with anti-TSHβ serum and strongly with anti-α-subunit serum. Northern blot analysis of RNA isolated from the tumor revealed TSHβ and α-subunit mRNA levels of normal length, while primer extension analysis showed a major initiation site for the TSHβ gene that appeared to be identical in the tumor and normal pituitary tissue. A second minor up-stream start site was detected in the tumor, but it represented less than 1% of transcription compared to the major downstream start site. We conclude that the tumor secreted TSH and α-subunit in an abnormal and discordant fashion, but that the TSH gene initiation site appeared to be normal and, therefore, did not explain the observed secretory abnormalities.

Original languageEnglish (US)
Pages (from-to)1211-1215
Number of pages5
JournalJournal of Clinical Endocrinology and Metabolism
Volume68
Issue number6
StatePublished - 1989
Externally publishedYes

Fingerprint

Pituitary Neoplasms
Thyrotropin
Tumors
Serum
Genes
Tissue
Transcription
Somatostatin
Iodine
Surgery
Dopamine
RNA
Neoplasms
Messenger RNA
Clinical Studies
Graves Disease
Hyperthyroidism
Northern Blotting

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Samuels, M., Wood, W. M., Gordon, D. F., Kleinschmidt-DeMasters, B. K., Lillehei, K., & Ridgway, E. C. (1989). Clinical and molecular studies of a thyrotropin-secreting pituitary adenoma. Journal of Clinical Endocrinology and Metabolism, 68(6), 1211-1215.

Clinical and molecular studies of a thyrotropin-secreting pituitary adenoma. / Samuels, Mary; Wood, W. M.; Gordon, D. F.; Kleinschmidt-DeMasters, B. K.; Lillehei, K.; Ridgway, E. C.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 68, No. 6, 1989, p. 1211-1215.

Research output: Contribution to journalArticle

Samuels, M, Wood, WM, Gordon, DF, Kleinschmidt-DeMasters, BK, Lillehei, K & Ridgway, EC 1989, 'Clinical and molecular studies of a thyrotropin-secreting pituitary adenoma', Journal of Clinical Endocrinology and Metabolism, vol. 68, no. 6, pp. 1211-1215.
Samuels M, Wood WM, Gordon DF, Kleinschmidt-DeMasters BK, Lillehei K, Ridgway EC. Clinical and molecular studies of a thyrotropin-secreting pituitary adenoma. Journal of Clinical Endocrinology and Metabolism. 1989;68(6):1211-1215.
Samuels, Mary ; Wood, W. M. ; Gordon, D. F. ; Kleinschmidt-DeMasters, B. K. ; Lillehei, K. ; Ridgway, E. C. / Clinical and molecular studies of a thyrotropin-secreting pituitary adenoma. In: Journal of Clinical Endocrinology and Metabolism. 1989 ; Vol. 68, No. 6. pp. 1211-1215.
@article{3c17b5e88b5e425cb074367558b018d9,
title = "Clinical and molecular studies of a thyrotropin-secreting pituitary adenoma",
abstract = "A 40-year-old woman, who had previously received radioactive iodine for hyperthyroidism, presumably due to Graves' disease, subsequently was found to have inappropriately elevated serum TSH and α-subunit levels and a pituitary adenoma. Detailed clinical studies revealed marked serum TSH elevations (~100 mU/L) with no circadian variation, but with 7 pulses/24 h. Serum α-subunit levels averaged 2.5 μg/L, with 13 pulses/24 h. Neither serum TSH nor α-subunit responded to TRH stimulation, nor did serum TSH change during dopamine infusion, but α-subunit levels did decline slightly. In contrast, during somatostatin infusion, serum TSH declined to 30{\%} of baseline levels, while α-subunit levels did not change. Pituitary adenoma tissue obtained at the time of transsphenoidal surgery immunostained weakly with anti-TSHβ serum and strongly with anti-α-subunit serum. Northern blot analysis of RNA isolated from the tumor revealed TSHβ and α-subunit mRNA levels of normal length, while primer extension analysis showed a major initiation site for the TSHβ gene that appeared to be identical in the tumor and normal pituitary tissue. A second minor up-stream start site was detected in the tumor, but it represented less than 1{\%} of transcription compared to the major downstream start site. We conclude that the tumor secreted TSH and α-subunit in an abnormal and discordant fashion, but that the TSH gene initiation site appeared to be normal and, therefore, did not explain the observed secretory abnormalities.",
author = "Mary Samuels and Wood, {W. M.} and Gordon, {D. F.} and Kleinschmidt-DeMasters, {B. K.} and K. Lillehei and Ridgway, {E. C.}",
year = "1989",
language = "English (US)",
volume = "68",
pages = "1211--1215",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "6",

}

TY - JOUR

T1 - Clinical and molecular studies of a thyrotropin-secreting pituitary adenoma

AU - Samuels, Mary

AU - Wood, W. M.

AU - Gordon, D. F.

AU - Kleinschmidt-DeMasters, B. K.

AU - Lillehei, K.

AU - Ridgway, E. C.

PY - 1989

Y1 - 1989

N2 - A 40-year-old woman, who had previously received radioactive iodine for hyperthyroidism, presumably due to Graves' disease, subsequently was found to have inappropriately elevated serum TSH and α-subunit levels and a pituitary adenoma. Detailed clinical studies revealed marked serum TSH elevations (~100 mU/L) with no circadian variation, but with 7 pulses/24 h. Serum α-subunit levels averaged 2.5 μg/L, with 13 pulses/24 h. Neither serum TSH nor α-subunit responded to TRH stimulation, nor did serum TSH change during dopamine infusion, but α-subunit levels did decline slightly. In contrast, during somatostatin infusion, serum TSH declined to 30% of baseline levels, while α-subunit levels did not change. Pituitary adenoma tissue obtained at the time of transsphenoidal surgery immunostained weakly with anti-TSHβ serum and strongly with anti-α-subunit serum. Northern blot analysis of RNA isolated from the tumor revealed TSHβ and α-subunit mRNA levels of normal length, while primer extension analysis showed a major initiation site for the TSHβ gene that appeared to be identical in the tumor and normal pituitary tissue. A second minor up-stream start site was detected in the tumor, but it represented less than 1% of transcription compared to the major downstream start site. We conclude that the tumor secreted TSH and α-subunit in an abnormal and discordant fashion, but that the TSH gene initiation site appeared to be normal and, therefore, did not explain the observed secretory abnormalities.

AB - A 40-year-old woman, who had previously received radioactive iodine for hyperthyroidism, presumably due to Graves' disease, subsequently was found to have inappropriately elevated serum TSH and α-subunit levels and a pituitary adenoma. Detailed clinical studies revealed marked serum TSH elevations (~100 mU/L) with no circadian variation, but with 7 pulses/24 h. Serum α-subunit levels averaged 2.5 μg/L, with 13 pulses/24 h. Neither serum TSH nor α-subunit responded to TRH stimulation, nor did serum TSH change during dopamine infusion, but α-subunit levels did decline slightly. In contrast, during somatostatin infusion, serum TSH declined to 30% of baseline levels, while α-subunit levels did not change. Pituitary adenoma tissue obtained at the time of transsphenoidal surgery immunostained weakly with anti-TSHβ serum and strongly with anti-α-subunit serum. Northern blot analysis of RNA isolated from the tumor revealed TSHβ and α-subunit mRNA levels of normal length, while primer extension analysis showed a major initiation site for the TSHβ gene that appeared to be identical in the tumor and normal pituitary tissue. A second minor up-stream start site was detected in the tumor, but it represented less than 1% of transcription compared to the major downstream start site. We conclude that the tumor secreted TSH and α-subunit in an abnormal and discordant fashion, but that the TSH gene initiation site appeared to be normal and, therefore, did not explain the observed secretory abnormalities.

UR - http://www.scopus.com/inward/record.url?scp=0024405086&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024405086&partnerID=8YFLogxK

M3 - Article

C2 - 2723029

AN - SCOPUS:0024405086

VL - 68

SP - 1211

EP - 1215

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 6

ER -